Inflammation and Therapy for Respiratory Virus Infection
Inflammation and Therapy for Respiratory Virus Infection
批准号:
10272105
负责人:
HELENE ROSENBERG
金额:
$47.31万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAcute respiratory infectionAnimal ModelAntihypertensive AgentsAntiviral AgentsBlood VesselsCandidate Disease GeneCapillary Leak SyndromeCessation of lifeCharacteristicsChromosome 6ClinicalDevelopmentDiseaseEdemaEtiologyExtravasationFamilyGeneticGenetic DeterminismHistamineHumanHypersensitivityInbred MouseInbred Strains MiceInfantInfectionInflammationInflammatoryInflammatory ResponseInfluenza A virusInterruptionKnowledgeLactobacillusLactobacillus plantarumLigandsLiquid substanceManuscriptsMapsMediatingModelingMolecularMurine pneumonia virusMusNamesPathologicPathologyPattern recognition receptorPeripheralPlayPredispositionProteinsReagentRecurrenceReportingResearchRespiratory FailureRespiratory MucosaRespiratory Syncytial Virus InfectionsRespiratory SystemRespiratory TherapyRobin birdRoleSeriesShockSignal TransductionSourceSyndromeTherapeuticTissuesVirusVirus ReplicationWild Type MouseWorkWritingcytokinegenetic analysisgenomic locusin vivointerestmouse modelpathogenrespiratoryrespiratory infection virusresponsetraittreatment strategy
中文摘要
正在进行的研究重点是探索对急性呼吸道病毒感染的病理炎症反应,并利用这些信息制定创造性的策略,以避免这种疾病的致命后遗症。
在2020财年,我们贡献了一(1)篇原始研究文稿:
手稿#1:
标题:一种自然小鼠模型揭示了系统性毛细血管渗漏综合征的遗传决定因素
(克拉克森病)。
全身性毛细血管渗漏综合征(SCLS,Clarkson病)是一种病因不明的疾病,其特征是反复发作的蛋白质和液体渗漏到周围组织,导致全身浮肿和低血压休克。SCLS的发病机制和遗传学基础仍不清楚。在这里,我们确定了一个近亲交配的小鼠品系SJL,它概括了SCLS的基本特征,包括对组胺和感染引发的血管泄漏的敏感性。我们将这一特征命名为组胺高敏感性(HHS/HHS),并将其定位在6号染色体上。HHS与人类中与SCLS关联最强的基因组位点(3p25.3)同线,揭示了发生血管高通透性的易感性具有在人和小鼠之间保守的强大遗传成分,并为SCLS提供了一个自然发生的动物模型。对HHS的遗传分析可能揭示出同源候选基因,这些基因不仅对SCLS有贡献,而且对更广泛的血管屏障功能的正常和失调机制也有贡献。
我们的贡献:我们提供专业知识和试剂,帮助探索这些小鼠对急性呼吸道病毒感染的反应,急性呼吸道病毒感染是引发这种综合征血管渗漏的主要病理生理因素之一。
裁判:拉扎·A,谢正,陈EC,陈伟,斯科特·兰姆,罗宾·艾施,克雷门佐夫·迪恩,罗森博格,帕里克·SM,布兰肯霍恩EP,特舍尔·C,德雷·公里。2019年。共产主义生物。2:398。
英文摘要
Ongoing research focuses on the exploration of pathologic inflammatory responses to acute respiratory virus infection and the use of this information to develop creative strategies to circumvent the lethal sequelae characteristic of this disease.
In Fiscal year (FY) 2020, we contributed to one (1) original research manuscript:
Manuscript #1:
Title: A natural mouse model reveals genetic determinants of systemic capillary leak syndrome
(Clarkson disease).
The systemic capillary leak syndrome (SCLS, Clarkson disease) is a disorder of unknown etiology characterized by recurrent episodes of vascular leakage of proteins and fluids into peripheral tissues, resulting in whole-body edema and hypotensive shock. The pathologic mechanisms and genetic basis for SCLS remain elusive. Here we identify an inbred mouse strain, SJL, which recapitulates cardinal features of SCLS, including susceptibility to histamine- and infection-triggered vascular leak. We named this trait "Histamine hypersensitivity" (Hhs/Hhs) and mapped it to Chromosome 6. Hhs is syntenic to the genomic locus most strongly associated with SCLS in humans (3p25.3), revealing that the predisposition to develop vascular hyperpermeability has a strong genetic component conserved between humans and mice and providing a naturally occurring animal model for SCLS. Genetic analysis of Hhs may reveal orthologous candidate genes that contribute not only to SCLS, but also to normal and dysregulated mechanisms underlying vascular barrier function more generally.
Our contribution: We provided expertise and reagents that facilitated an exploration of the responses of these mice to an acute respiratory virus infection, one of the major pathophysiologic factors that incite vascular leak in this syndrome.
Ref: Raza A, Xie Z, Chan EC, Chen WS, Scott LM, Robin Eisch A, Krementsov DN, Rosenberg HF, Parikh SM, Blankenhorn EP, Teuscher C, Druey KM. 2019. Commun Biol. 2:398.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.imlet.2016.02.012
发表时间:
2016-04
期刊:
Immunology letters
影响因子:
4.4
作者:
[Brenner TA, Rice TA, Anderson ED, Percopo CM, Rosenberg HF]
通讯作者:
Rosenberg HF
DOI:
10.1177/0009922810394834
发表时间:
2011-06
期刊:
Clinical pediatrics
影响因子:
1.6
作者:
[Suryadevara M, Cummings E, Bonville CA, Bartholoma N, Riddell S, Kiska D, Rosenberg HF, Domachowske JB]
通讯作者:
Domachowske JB
DOI:
10.4049/jimmunol.1002635
发表时间:
2011-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Davidson S, Kaiko G, Loh Z, Lalwani A, Zhang V, Spann K, Foo SY, Hansbro N, Uematsu S, Akira S, Matthaei KI, Rosenberg HF, Foster PS, Phipps S]
通讯作者:
Phipps S
Local production of CCL3, CCL11, and IFN-γ correlates with disease severity in murine parainfluenza virus infection.
CCL3、CCL11 和 IFN-γ 的本地产生与鼠副流感病毒感染的疾病严重程度相关。
DOI:
10.1186/1743-422x-10-357
发表时间:
2013
期刊:
Virology journal
影响因子:
4.8
作者:
[Suryadevara,Manika, Bonville,CynthiaA, Rosenberg,HeleneF, Domachowske,JosephB]
通讯作者:
Domachowske,JosephB
Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.
呼吸道合胞病毒(RSV)感染的炎症反应和免疫调节药物治疗的发展。
DOI:
10.2174/092986712799828346
发表时间:
2012
期刊:
Current medicinal chemistry
影响因子:
4.1
作者:
[Rosenberg HF, Domachowske JB]
通讯作者:
Domachowske JB
共 13 条
CARDIOTOXICITY OF EOSINOPHIL GRANULE CATIONIC PROTEINS
-
批准号:3087626
-
项目类别:
-
资助金额:$6.89万
-
财政年份:1989
-
负责人:HELENE ROSENBERG
-
依托单位:
CARDIOTOXICITY OF EOSINOPHIL GRANULE CATIONIC PROTEINS
-
批准号:3087628
-
项目类别:
-
资助金额:$8.39万
-
财政年份:1989
-
负责人:HELENE ROSENBERG
-
依托单位:
CARDIOTOXICITY OF EOSINOPHIL GRANULE CATIONIC PROTEINS
-
批准号:3087627
-
项目类别:
-
资助金额:$6.93万
-
财政年份:1989
-
负责人:HELENE ROSENBERG
-
依托单位:
HUMAN PHAGOCYTE GRANULE PROTEINS
-
批准号:6431620
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Inflammation and Therapy for Respiratory Virus Infection
-
批准号:7006273
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Molecular Biology of the Ribonuclease A Gene Superfamily
-
批准号:7964509
-
项目类别:
-
资助金额:$42.3万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Inflammation and Therapy for Respiratory Virus Infection
-
批准号:8745415
-
项目类别:
-
资助金额:$68.15万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Molecular Biology of the Ribonuclease A Gene Superfamily
-
批准号:7732597
-
项目类别:
-
资助金额:$68.17万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Molecular Biology of the Ribonuclease A Gene Superfamily
-
批准号:7196724
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Biology of the Eosinophilic Leukocyte
-
批准号:7592297
-
项目类别:
-
资助金额:$83.55万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Eosinophils, Inflammation and Immunity
-
批准号:9566631
-
项目类别:
-
资助金额:$65.59万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Biology of the Eosinophilic Leukocyte
-
批准号:7964507
-
项目类别:
-
资助金额:$117.34万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Inflammation and Therapy for Respiratory Virus Infection
-
批准号:8946378
-
项目类别:
-
资助金额:$61.75万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Inflammation and Therapy for Respiratory Virus Infection
-
批准号:7732598
-
项目类别:
-
资助金额:$73.65万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Molecular Biology of the Ribonuclease A Gene Superfamily
-
批准号:8156960
-
项目类别:
-
资助金额:$19.07万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Biology of the Eosinophilic Leukocyte
-
批准号:8156959
-
项目类别:
-
资助金额:$109.56万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Eosinophils, Inflammation and Immunity
-
批准号:10272104
-
项目类别:
-
资助金额:$47.31万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
HUMAN PHAGOCYTE GRANULE PROTEINS
-
批准号:6099004
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
HUMAN PHAGOCYTE GRANULE PROTEINS
-
批准号:6288908
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
Biology of the Eosinophilic Leukocyte
-
批准号:6987123
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:HELENE ROSENBERG
-
依托单位:
海外基金